Project Grant R01EB039021
- Federal Grant Award Summary The University of Texas at Arlington received a $378,411 Project Grant award effective April 1, 2026, from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project, which extends through January 31, 2030, focuses on developing a fundamentally novel super-resolution tomographic imaging technology capable of achieving...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the University of Texas at Dallas a $499,156 Project Grant, effective June 1, 2026 through March 31, 2030, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award supports development of a first-in-kind acoustic blood oxygen level dependent (BOLD) imaging technology designed to enable noninvasive, bedside monitoring of...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $623,432 Project Grant award on May 7, 2026, from the National Cancer Institute under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop enhanced imaging technology for fluorescence-guided surgery (FGS). The award supports advancement of the Cancer Vision Goggle (CVG) system through three primary technical enhancements: transitioning from monocular to stereoscopic vision...
- Federal Grant Award Summary The University of Texas at Dallas received a $621,980 Project Grant award effective September 1, 2025, through August 31, 2028, from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project focuses on developing sliding microgel-based synthetic platelets designed to address uncontrolled bleeding in trauma patients. The research...
- Federal Grant Award Summary The University of Texas at Austin received a $618,695 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded April 20, 2026, with completion targeted for March 31, 2029. This three-year feasibility effort delivers the design, development, integration, and validation of an adaptive and reconfigurable...
- Federal Grant Award Summary The University of Texas at Austin received a $581,518 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective July 1, 2026, through May 31, 2030. The award funds development of a biomechanics-aware, image-guided surgical robotic workstation designed to advance minimally invasive spinal fixation procedures....
- Federal Grant Award Summary Texas A&M Engineering Experiment Station received a $395,695 Project Grant award dated August 1, 2025, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), administered by the National Institute of Biomedical Imaging and Bioengineering (NIBIB). The four-year project, extending through July 31, 2029, will develop novel multi-modal ultrasound imaging methods designed to serve as predictive markers...
- Federal Grant Award Summary The University of Texas at Austin received a $481,329 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded April 16, 2026, with completion targeted for March 31, 2030. This award funds the development of a flexible robotic ablation system integrated with laser speckle contrast imaging technology to assist...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $1.29 million Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop enhanced imaging and analysis tools for lymphoscintigraphy (LSG) in lymphedema diagnosis and management. The three-year project (September 1, 2025–August 31, 2028)...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded a $429,000 Project Grant to The Regents of the University of Colorado (University of Colorado-Denver) effective April 1, 2026, with completion targeted for March 31, 2028. The award supports research and development of PLGA (poly(lactic-co-glycolic acid))-encapsulated...
The University of Texas at Dallas received a $486,805 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective July 1, 2026 through April 30, 2030. The award supports development of renal-clearable gold nanoparticles engineered to enable margination-mediated delivery and glutathione-triggered release of fluorescent agents for improved intraoperative visualization during brain metastasis surgery. The project addresses critical limitations in current fluorescence-guided surgery (FGS) technologies, including 5-aminolevulinic acid (5-ALA) and indocyanine green (ICG), which fail to detect approximately 60–80% of brain metastases and infiltrative tumor margins due to minimal blood-brain barrier disruption in these lesions. This technology development initiative represents NIBIB's strategic investment in novel bioengineering tools for surgical imaging and oncological intervention. The nanoparticle platform is designed to overcome existing detection gaps by leveraging passive targeting mechanisms and stimulus-responsive release kinetics to achieve enhanced tumor accumulation and visualization with improved surgical precision. Upon successful completion, this research is expected to advance the state of intraoperative imaging modalities and provide neurosurgeons with enhanced capability to identify and resect occult metastatic disease, thereby reducing recurrence rates and improving patient outcomes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $486.8k | 6/25/26 |